HENRY SCHEIN INC (HSIC) Options Risk Score
Real-time risk analysis for HSIC options traders — updated every 30 minutes.
Data last updated: 2026-07-23
Run a full HSIC options risk analysis
See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.
Scan HSIC Now — Free →
Is it risky to sell options on HENRY SCHEIN INC (HSIC) right now?
Over a 4-week expiry window, HENRY SCHEIN INC (HSIC) scores 100 out of 100 for options catalyst risk (HIGH). The contributing signals are an upcoming earnings report, 11 recent news items, 3 active legal filings and 1 clinical-trial catalyst within the 4-week window. Anything at 70 or above counts as HIGH, meaning the premium on HSIC is at least partly compensation for a scheduled event rather than pure time value. It says nothing about direction — only that something is on the calendar.
HSIC shows an IV Rank of 100 — implied volatility is near the top of its own one-year range, so HSIC options are historically expensive, which favours premium-selling strategies, with a current implied volatility of about 76%. IV Rank answers how HSIC options are priced against their own history, which is the starting point for choosing between selling and buying premium.
HSIC is scheduled to report earnings on 2026-08-04, which falls inside a typical monthly options expiry — expect elevated implied volatility into the event and an IV crush afterward.
TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer